Nextech Invest

Latest statistics and disclosures from Nextech Invest's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are RVMD, TYRA, ORIC, CRGX, TNGX, and represent 73.91% of Nextech Invest's stock portfolio.
  • Added to shares of these 3 stocks: ALMS (+$16M), ZYME (+$14M), MRSN.
  • Started 2 new stock positions in ZYME, ALMS.
  • Reduced shares in these 2 stocks: SPRY (-$12M), CGEM.
  • Nextech Invest was a net buyer of stock by $22M.
  • Nextech Invest has $712M in assets under management (AUM), dropping by 19.82%.
  • Central Index Key (CIK): 0001911010

Tip: Access up to 7 years of quarterly data

Positions held by Nextech Invest consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Nextech Invest

Nextech Invest holds 15 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Revolution Medicines (RVMD) 40.1 $286M 6.3M 45.35
 View chart
Tyra Biosciences (TYRA) 13.4 $95M 4.1M 23.51
 View chart
Oric Pharmaceuticals (ORIC) 7.6 $54M 5.3M 10.25
 View chart
Cargo Therapeutics (CRGX) 6.8 $49M 2.6M 18.45
 View chart
Tango Therapeutics (TNGX) 6.0 $43M 5.5M 7.70
 View chart
Arvinas Ord (ARVN) 4.9 $35M 1.4M 24.63
 View chart
Relay Therapeutics (RLAY) 3.8 $27M 3.8M 7.08
 View chart
Mersana Therapeutics (MRSN) 3.2 $23M +26% 12M 1.89
 View chart
Cullinan Oncology (CGEM) 2.7 $19M -6% 1.1M 16.74
 View chart
Silence Therapeutics Ads (SLN) 2.4 $17M 952k 18.18
 View chart
Silverback Therapeutics (SPRY) 2.3 $16M -41% 1.1M 14.50
 View chart
Alumis (ALMS) 2.2 $16M NEW 1.5M 10.68
 View chart
Context Therapeutics (CNTX) 2.0 $15M 7.4M 1.96
 View chart
Zymeworks Del (ZYME) 2.0 $14M NEW 1.1M 12.55
 View chart
Boundless Bio (BOLD) 0.6 $4.3M 1.2M 3.47
 View chart

Past Filings by Nextech Invest

SEC 13F filings are viewable for Nextech Invest going back to 2021